Founded with a mission to revolutionize drug delivery, i2o Therapeutics focuses on developing safe and effective oral formulations for therapies traditionally limited to injections. The company aims to enhance patient outcomes by creating innovative delivery platforms for biologics and peptides, which can significantly improve the convenience and compliance of treatments.
Their market focus includes patients and healthcare providers seeking more accessible and less invasive therapeutic options.nni2o Therapeutics has attracted notable investors and industry leaders who recognize the potential impact of their technology. The company's achievements include successful preclinical trials demonstrating the efficacy of their oral formulations. By transforming injectable therapies into oral medications, i2o Therapeutics is poised to make a significant impact on the biotech industry, improving the quality of life for patients worldwide.
